SPY389.58+9.22 2.42%
DIA315.59+6.14 1.98%
IXIC13,588.83+396.48 3.01%

Regeneron Says It Is Evaluating A Lower Dose Of The Antibody Therapy And Should The Lower Dose Win U.S. Emergency Use Authorization, Co Aims To Deliver Up To 1.25M Doses By June 30

-Conference Call

· 02/05/2021 09:36